<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25036464</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>7</Issue><PubDate><Year>2014</Year><Month>Jul</Month><Day>17</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening.</ArticleTitle><Pagination><StartPage>2778</StartPage><EndPage>2795</EndPage><MedlinePgn>2778-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/v6072778</ELocationID><Abstract><AbstractText>Hand, foot and mouth disease (HFMD) is a common pediatric illness mainly caused by infection with enterovirus 71 (EV71) and coxsackievirus A16 (CA16). The frequent HFMD outbreaks have become a serious public health problem. Currently, no vaccine or antiviral drug for EV71/CA16 infections has been approved. In this study, a two-step screening platform consisting of reporter virus-based assays and cell viability&#x2011;based assays was developed to identify potential inhibitors of EV71/CA16 infection. Two types of reporter viruses, a pseudovirus containing luciferase-encoding RNA replicons encapsidated by viral capsid proteins and a full-length reporter virus containing enhanced green fluorescent protein, were used for primary screening of 400 highly purified natural compounds. Thereafter, a cell viability-based secondary screen was performed for the identified hits to confirm their antiviral activities. Three compounds (luteolin, galangin, and quercetin) were identified, among which luteolin exhibited the most potent inhibition of viral infection. In the cell viability assay and plaque reduction assay, luteolin showed similar 50% effective concentration (EC50) values of about 10 &#x3bc;M. Luteolin targeted the post-attachment stage of EV71 and CA16 infection by inhibiting viral RNA replication. This study suggests that luteolin may serve as a lead compound to develop potent anti-EV71 and CA16 drugs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. xulinjlu@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Weiheng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. suweiheng@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. jun.jin@pasteur.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jiawen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. JiawenChen229@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. lixiaojun3345@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xuyuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. zxy_better@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Meiyan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. sunmy990@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Shiyang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. sunbaoshiyang@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Peihu</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. fph121@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. andonginlab@sina.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Huafei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. bszhfing@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiguang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. zxy_better@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. weikong@jlu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Tonghui</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>College of Basic Medical Sciences, Dalian Medical University, Dalian 116000, China. tonghuima@dlmedu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Chunlai</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Jilin University, Changchun 130012, China. jiangcl@jlu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001688">Biological Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005419">Flavonoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C485184">enhanced green fluorescent protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>142FWE6ECS</RegistryNumber><NameOfSubstance UI="C037032">galangin</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9IKM0I5T1E</RegistryNumber><NameOfSubstance UI="D011794">Quercetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.12.-</RegistryNumber><NameOfSubstance UI="D008156">Luciferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>KUX1ZNC9J2</RegistryNumber><NameOfSubstance UI="D047311">Luteolin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001688" MajorTopicYN="N">Biological Products</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005419" MajorTopicYN="N">Flavonoids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015967" MajorTopicYN="Y">Gene Expression Regulation, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057166" MajorTopicYN="N">High-Throughput Screening Assays</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047311" MajorTopicYN="N">Luteolin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011794" MajorTopicYN="N">Quercetin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012093" MajorTopicYN="N">Replicon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25036464</ArticleId><ArticleId IdType="pmc">PMC4113793</ArticleId><ArticleId IdType="doi">10.3390/v6072778</ArticleId><ArticleId IdType="pii">v6072778</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Qiu J. Enterovirus 71 infection: A new threat to global public health? Lancet Neurol. 2008;7:868&#x2013;869. doi: 10.1016/S1474-4422(08)70207-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70207-2</ArticleId><ArticleId IdType="pmc">PMC7128195</ArticleId><ArticleId IdType="pubmed">18848307</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T., Chikahira M., Yoshida S., Ebira H., Hasegawa A., Totsuka A., Nishio O. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in japan during the summer of 2000: Detection and molecular epidemiology of enterovirus 71. Microbiol. Immunol. 2002;46:621&#x2013;627. doi: 10.1111/j.1348-0421.2002.tb02743.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2002.tb02743.x</ArticleId><ArticleId IdType="pubmed">12437029</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L.G., Parashar U.D., Lye M.S., Ong F.G., Zaki S.R., Alexander J.P., Ho K.K., Han L.L., Pallansch M.A., Suleiman A.B., et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: Clinical and pathological characteristics of the disea. For the outbreak study group. Clin. Infect. Dis. 2000;31:678&#x2013;683. doi: 10.1086/314032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad K. Hand, foot, and mouth disease outbreak reported in singapore. Lancet. 2000;356:1338. doi: 10.1016/S0140-6736(05)74253-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)74253-7</ArticleId><ArticleId IdType="pubmed">11073035</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Wpro hand, foot and mouth disease situation update, 15 January 2014.  [(accessed on 17 May 2014)].  Available online: http://www.wpro.who.int/emerging_diseases/HFMD.Biweekly.15Jan2014.pdf?ua=1.</Citation></Reference><Reference><Citation>Ang L.W., Koh B.K., Chan K.P., Chua L.T., James L., Goh K.T. Epidemiology and control of hand, foot and mouth disease in singapore, 2001&#x2013;2007. Ann. Acad. Med. Singapore. 2009;38:106&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenau H.F., Richter M., Doerr H.W. Hand, foot and mouth disease: Seroprevalence of coxsackie a16 and enterovirus 71 in germany. Med. Microbiol. Immunol. 2010;199:45&#x2013;51. doi: 10.1007/s00430-009-0133-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-009-0133-6</ArticleId><ArticleId IdType="pubmed">19941005</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Yi L., Su J., Lu J., Zeng H., Guan D., Ma C., Zhang W., Xiao H., Li H., et al. Seroepidemiology of human enterovirus71 and coxsackievirusa16 among children in guangdong province, china. BMC Infect. Dis. 2013;13:322. doi: 10.1186/1471-2334-13-322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-13-322</ArticleId><ArticleId IdType="pmc">PMC3717138</ArticleId><ArticleId IdType="pubmed">23855481</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip C.C., Lau S.K., Zhou B., Zhang M.X., Tsoi H.W., Chan K.H., Chen X.C., Woo P.C., Yuen K.Y. Emergence of enterovirus 71 "double-recombinant" strains belonging to a novel genotype d originating from southern china: First evidence for combination of intratypic and intertypic recombination events in ev71. Arch. Virol. 2010;155:1413&#x2013;1424. doi: 10.1007/s00705-010-0722-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-010-0722-0</ArticleId><ArticleId IdType="pmc">PMC7087135</ArticleId><ArticleId IdType="pubmed">20549263</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhu Z., Yang W., Ren J., Tan X., Wang Y., Mao N., Xu S., Zhu S., Cui A., et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in fuyang city of china. Virol. J. 2010;7:94. doi: 10.1186/1743-422X-7-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L., Xu M., Yin Z. Antiviral drug discovery for the treatment of enterovirus 71 infections. Antivir. Res. 2013;97:183&#x2013;194. doi: 10.1016/j.antiviral.2012.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.005</ArticleId><ArticleId IdType="pubmed">23261847</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z.-L., Mao Q.-Y., Wang Y.-P., Zhu F.-C., Li J.-X., Yao X., Gao F., Wu X., Xu M., Wang J. Progress on the research and development of inactivated ev71 whole-virus vaccines. Hum. Vaccin. Immunother. 2013;9:1701&#x2013;1705. doi: 10.4161/hv.24949.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.24949</ArticleId><ArticleId IdType="pmc">PMC3906269</ArticleId><ArticleId IdType="pubmed">23744508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q.C., Wang Y., Liu Y.P., Zhang R.Q., Li X., Su W.H., Long F., Luo X.D., Peng T. Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin. Eur. J. Pharm. Sci. 2011;44:392&#x2013;398. doi: 10.1016/j.ejps.2011.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejps.2011.08.030</ArticleId><ArticleId IdType="pubmed">21914477</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Chen X., Wang W., Zhang Y., Yang Z., Jin Y., Ge H.M., Li E., Yang G. Glycyrrhizic acid as the antiviral component of glycyrrhiza uralensis fisch. Against coxsackievirus a16 and enterovirus 71 of hand foot and mouth disease. J. Ethnopharmacol. 2013;147:114&#x2013;121. doi: 10.1016/j.jep.2013.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2013.02.017</ArticleId><ArticleId IdType="pmc">PMC7125661</ArticleId><ArticleId IdType="pubmed">23454684</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Xiu J., Zhang X., Zhang L., Yan K., Qin C., Liu J. Antiviral effect of matrine against human enterovirus 71. Molecules. 2012;17:10370&#x2013;10376. doi: 10.3390/molecules170910370.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules170910370</ArticleId><ArticleId IdType="pmc">PMC6268984</ArticleId><ArticleId IdType="pubmed">22932217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.C., Chang H.Y., Lin P.F., Chern J.H., Hsu J.T., Chang C.Y., Shih S.R. Novel antiviral agent dtrip-22 targets rna-dependent rna polymerase of enterovirus 71. Antimicrob. Agents Chemother. 2009;53:2740&#x2013;2747. doi: 10.1128/AAC.00101-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00101-09</ArticleId><ArticleId IdType="pmc">PMC2704669</ArticleId><ArticleId IdType="pubmed">19414569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Song Z., Qin B., Zhang X., Chen L., Hu Y., Yuan Z. Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: Evaluation of antiviral efficacy in a murine infection model. Antivir. Res. 2013;97:264&#x2013;269. doi: 10.1016/j.antiviral.2012.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.029</ArticleId><ArticleId IdType="pubmed">23295352</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.C., Liu S.C., Huang P.N., Chang H.Y., Chern J.H., Shih S.R. Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants. J. Biomed. Sci. 2008;15:291&#x2013;300. doi: 10.1007/s11373-007-9228-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11373-007-9228-5</ArticleId><ArticleId IdType="pubmed">18196474</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Wakita T., Shimizu H. Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. J. Gen. Virol. 2008;89:2518&#x2013;2530. doi: 10.1099/vir.0.2008/002915-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/002915-0</ArticleId><ArticleId IdType="pubmed">18796721</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble C.G., Chen Y.L., Dong H., Gu F., Lim S.P., Schul W., Wang Q.Y., Shi P.Y. Strategies for development of dengue virus inhibitors. Antivir. Res. 2010;85:450&#x2013;462. doi: 10.1016/j.antiviral.2009.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.12.011</ArticleId><ArticleId IdType="pubmed">20060421</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudmundsdottir H.S., Olafsdottir K., Franzdottir S.R., Andresdottir V. Construction and characterization of an infectious molecular clone of maedi-visna virus that expresses green fluorescent protein. J. Virol. Meth. 2010;168:98&#x2013;102. doi: 10.1016/j.jviromet.2010.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2010.04.026</ArticleId><ArticleId IdType="pubmed">20447418</ArticleId></ArticleIdList></Reference><Reference><Citation>Marriott A.C., Hornsey C.A. Reverse genetics system for chandipura virus: Tagging the viral matrix protein with green fluorescent protein. Virus Res. 2011;160:166&#x2013;172. doi: 10.1016/j.virusres.2011.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2011.06.007</ArticleId><ArticleId IdType="pubmed">21704089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.S., Keum S.J., Jang S.K. Generation of a cell culture-adapted hepatitis c virus with longer half life at physiological temperature. PLoS One. 2011;6:e22808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3150383</ArticleId><ArticleId IdType="pubmed">21829654</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsueng G., Tabor-Godwin J.M., Gopal A., Ruller C.M., Deline S., An N., Frausto R.F., Milner R., Crocker S.J., Whitton J.L., et al. Coxsackievirus preferentially replicates and induces cytopathic effects in undifferentiated neural progenitor cells. J. Virol. 2011;85:5718&#x2013;5732. doi: 10.1128/JVI.02261-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02261-10</ArticleId><ArticleId IdType="pmc">PMC3126326</ArticleId><ArticleId IdType="pubmed">21471247</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang B., Deng C., Ye H., Xu W., Yuan Z., Shi P.Y., Zhang B. Development and characterization of a stable egfp enterovirus 71 for antiviral screening. Antivir. Res. 2013;97:198&#x2013;205. doi: 10.1016/j.antiviral.2012.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.010</ArticleId><ArticleId IdType="pubmed">23267829</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor b2 is a cellular receptor for enterovirus 71. Nat. Med. 2009;15:798&#x2013;801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Fan P., Jin J., Su W., An D., Xu L., Sun S., Zhang Y., Meng X., Gao F., et al. Establishment of cell lines with increased susceptibility to ev71/ca16 by stable overexpression of scarb2. Virol. J. 2013;10:250. doi: 10.1186/1743-422X-10-250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-250</ArticleId><ArticleId IdType="pmc">PMC3765843</ArticleId><ArticleId IdType="pubmed">23919614</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Ma H., Xu L., An D., Sun S., Huang X., Kong W., Jiang C. Development of a coxsackievirus a16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum. J. Virol. Meth. 2013;187:362&#x2013;367. doi: 10.1016/j.jviromet.2012.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.11.014</ArticleId><ArticleId IdType="pmc">PMC7112850</ArticleId><ArticleId IdType="pubmed">23178532</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Xu L., Guo S., Sun S., Zhang S., Zhu C., Kong W., Jiang C. Safe and objective assay of enterovirus 71 neutralizing antibodies via pseudovirus. Chem. Res. Chin. Univ. 2012;28:91&#x2013;95.</Citation></Reference><Reference><Citation>Troupin C., Dehee A., Schnuriger A., Vende P., Poncet D., Garbarg-Chenon A. Rearranged genomic rna segments offer a new approach to the reverse genetics of rotaviruses. J. Virol. 2010;84:6711&#x2013;6719. doi: 10.1128/JVI.00547-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00547-10</ArticleId><ArticleId IdType="pmc">PMC2903292</ArticleId><ArticleId IdType="pubmed">20427539</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Zhao J., Yu J., Chen Y., Lin M.C., Kung H.F., He M.L. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 2012;86:3767&#x2013;3776. doi: 10.1128/JVI.06687-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938;27:493&#x2013;497.</Citation></Reference><Reference><Citation>Marschall M., Freitag M., Weiler S., Sorg G., Stamminger T. Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents. Antimicrob. Agents Chemother. 2000;44:1588&#x2013;1597. doi: 10.1128/AAC.44.6.1588-1597.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.44.6.1588-1597.2000</ArticleId><ArticleId IdType="pmc">PMC89918</ArticleId><ArticleId IdType="pubmed">10817714</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo J., Quinn K.K., Kye S., Cooper P., Damoiseaux R., Krogstad P. Fluoxetine is a potent inhibitor of coxsackievirus replication. Antimicrob. Agents Chemother. 2012;56:4838&#x2013;4844. doi: 10.1128/AAC.00983-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00983-12</ArticleId><ArticleId IdType="pmc">PMC3421851</ArticleId><ArticleId IdType="pubmed">22751539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirrone V., Passic S., Wigdahl B., Rando R.F., Labib M., Krebs F.C. A styrene-alt-maleic acid copolymer is an effective inhibitor of r5 and x4 human immunodeficiency virus type 1 infection. J. Biomed. Biotechnol. 2010;2010:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879553</ArticleId><ArticleId IdType="pubmed">20589074</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhuis M., van Maarseveen N., Schuurman R., Verkuijlen S., de Vos M., Hendriksen K., van Loon A.M. Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time pcr. J. Clin. Microbiol. 2002;40:3666&#x2013;3670. doi: 10.1128/JCM.40.10.3666-3670.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.10.3666-3670.2002</ArticleId><ArticleId IdType="pmc">PMC130891</ArticleId><ArticleId IdType="pubmed">12354863</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.H. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999;4:67&#x2013;73. doi: 10.1177/108705719900400206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/108705719900400206</ArticleId><ArticleId IdType="pubmed">10838414</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H.C., Chen T.C., Fang M.Y., Yen K.J., Shih S.R., Hsu J.T., Tseng C.P. Inhibition of enterovirus 71 replication and the viral 3d polymerase by aurintricarboxylic acid. J. Antimicrob. Chemother. 2010;65:676&#x2013;683. doi: 10.1093/jac/dkp502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkp502</ArticleId><ArticleId IdType="pmc">PMC7110181</ArticleId><ArticleId IdType="pubmed">20089540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J.S., Wang K.C., Chiang L.C. Sheng-ma-ge-gen-tang inhibited enterovirus 71 infection in human foreskin fibroblast cell line. J. Ethnopharmacol. 2008;119:104&#x2013;108. doi: 10.1016/j.jep.2008.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2008.06.004</ArticleId><ArticleId IdType="pubmed">18601992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.Y., Cheng M.L., Weng S.F., Leu Y.L., Chiu D.T. Antiviral effect of epigallocatechin gallate on enterovirus 71. J. Agr. Food Chem. 2009;57:6140&#x2013;6147. doi: 10.1021/jf901128u.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf901128u</ArticleId><ArticleId IdType="pubmed">19537794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.Y., Huang S.C., Zhang Y., Lai Z.R., Kung S.H., Chang Y.S., Lin C.W. Antiviral ability of kalanchoe gracilis leaf extract against enterovirus 71 and coxsackievirus a16. Evid. base. Compl. Alternative Med. 2012;2012:503165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3361180</ArticleId><ArticleId IdType="pubmed">22666293</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Xiu J., Liu J., Zhang L., Li X., Xu Y., Qin C., Zhang L. Chebulagic acid, a hydrolyzable tannin, exhibited antiviral activity in vitro and in vivo against human enterovirus 71. Int. J. Mol. Sci. 2013;14:9618&#x2013;9627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3676802</ArticleId><ArticleId IdType="pubmed">23644889</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagnola G., Gong P., Peersen O.B. High-throughput screening identification of poliovirus rna-dependent rna polymerase inhibitors. Antivir. Res. 2011;91:241&#x2013;251. doi: 10.1016/j.antiviral.2011.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.06.006</ArticleId><ArticleId IdType="pmc">PMC3159743</ArticleId><ArticleId IdType="pubmed">21722674</ArticleId></ArticleIdList></Reference><Reference><Citation>Falah N., Violot S., Decimo D., Berri F., Foucault-Grunenwald M.L., Ohlmann T., Schuffenecker I., Morfin F., Lina B., Riteau B., et al. Ex vivo and in vivo inhibition of human rhinovirus replication by a new pseudosubstrate of viral 2a protease. J. Virol. 2012;86:691&#x2013;704. doi: 10.1128/JVI.05263-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05263-11</ArticleId><ArticleId IdType="pmc">PMC3255852</ArticleId><ArticleId IdType="pubmed">22072773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.C., Shih S.R., Chang T.Y., Tseng H.Y., Shih Y.F., Yen K.J., Chen W.C., Shie J.J., Fang J.M., Liang P.H., et al. A mammalian cell-based reverse two-hybrid system for functional analysis of 3c viral protease of human enterovirus 71. Anal. Biochem. 2008;375:115&#x2013;123. doi: 10.1016/j.ab.2007.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2007.12.019</ArticleId><ArticleId IdType="pubmed">18190777</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig-Basagoiti F., Deas T.S., Ren P., Tilgner M., Ferguson D.M., Shi P.Y. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for west nile virus drug discovery. Antimicrob. Agents Chemother. 2005;49:4980&#x2013;4988. doi: 10.1128/AAC.49.12.4980-4988.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.49.12.4980-4988.2005</ArticleId><ArticleId IdType="pmc">PMC1315944</ArticleId><ArticleId IdType="pubmed">16304161</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips T., Jenkinson L., McCrae C., Thong B., Unitt J. Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds. J. Virol. Meth. 2011;173:182&#x2013;188. doi: 10.1016/j.jviromet.2011.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2011.02.002</ArticleId><ArticleId IdType="pubmed">21300110</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya Y., Shimizu M., Hiyama Y., Itoh K., Hashimoto Y., Nakayama M., Horie T., Morita N. Antiviral activity of natural occurring flavonoids in vitro. Chem. Pharm. Bull. (Tokyo) 1985;33:3881&#x2013;3886. doi: 10.1248/cpb.33.3881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/cpb.33.3881</ArticleId><ArticleId IdType="pubmed">4092287</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrijsen R., Everaert L., Boeye A. Antiviral activity of flavones and potentiation by ascorbate. J. Gen. Virol. 1988;69:1749&#x2013;1751. doi: 10.1099/0022-1317-69-7-1749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-69-7-1749</ArticleId><ArticleId IdType="pubmed">2839607</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehla R., Bivalkar-Mehla S., Chauhan A. A flavonoid, luteolin, cripples hiv-1 by abrogation of tat function. PLoS One. 2011;6:e27915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3227592</ArticleId><ArticleId IdType="pubmed">22140483</ArticleId></ArticleIdList></Reference><Reference><Citation>Manvar D., Mishra M., Kumar S., Pandey V.N. Identification and evaluation of anti hepatitis c virus phytochemicals from eclipta alba. J. Ethnopharmacol. 2012;144:545&#x2013;554. doi: 10.1016/j.jep.2012.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2012.09.036</ArticleId><ArticleId IdType="pmc">PMC3511619</ArticleId><ArticleId IdType="pubmed">23026306</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelinger G., Merfort I., Schempp C.M. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Medica. 2008;74:1667&#x2013;1677. doi: 10.1055/s-0028-1088314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0028-1088314</ArticleId><ArticleId IdType="pubmed">18937165</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>